NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹66.63 | ₹33.04 | ₹80.68 | ₹91.58 | ₹13.14 |
What is the latest Earnings Per Share (EPS) of NGL FINECHEM ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹66.63 |
| Mar2024 | ₹33.04 |
| Mar2023 | ₹80.68 |
| Mar2022 | ₹91.58 |
| Mar2021 | ₹13.14 |
How is Earnings Per Share (EPS) of NGL FINECHEM Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹66.63 | 101.66 | |
| Mar2024 | ₹33.04 | -59.05 | |
| Mar2023 | ₹80.68 | -11.90 | |
| Mar2022 | ₹91.58 | 596.96 | |
| Mar2021 | ₹13.14 | - | |
Compare Earnings Per Share (EPS) of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,401.8 Cr | 3.6% | 52.1% | 79.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,054.0 Cr | 0.6% | 7% | 1.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,075.0 Cr | 1.6% | 4.6% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,904.0 Cr | 3.1% | 5.9% | 39% | Stock Analytics | |
| CIPLA | ₹107,358.0 Cr | 1.5% | -2.1% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,813.0 Cr | 0.5% | 9.8% | 5.7% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 3.6% |
52.1% |
79.7% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses